Krämer A, Bochtler T, Pauli C et al (2023) Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆. Ann Oncol 34:228–246. https://doi.org/10.1016/j.annonc.2022.11.013

Article  PubMed  Google Scholar 

Pavlidis N, Pentheroudakis G (2012) Cancer of unknown primary site. The Lancet 379:1428–1435. https://doi.org/10.1016/S0140-6736(11)61178-1

Article  Google Scholar 

Rassy E, Pavlidis N (2020) Progress in refining the clinical management of cancer of unknown primary in the molecular era. Nat Rev Clin Oncol 17:541–554. https://doi.org/10.1038/s41571-020-0359-1

Article  PubMed  Google Scholar 

Dermawan JK, Rubin BP (2021) The role of molecular profiling in the diagnosis and management of metastatic undifferentiated cancer of unknown primary✰: molecular profiling of metastatic cancer of unknown primary. Semin Diagn Pathol 38:193–198. https://doi.org/10.1053/j.semdp.2020.12.001

Article  PubMed  Google Scholar 

Tran KA, Kondrashova O, Bradley A et al (2021) Deep learning in cancer diagnosis, prognosis and treatment selection. Genome Med 13:152. https://doi.org/10.1186/s13073-021-00968-x

Article  PubMed  PubMed Central  Google Scholar 

Shreve JT, Khanani SA, Haddad TC (2022) Artificial intelligence in oncology: current capabilities, future opportunities, and ethical considerations. Am Soc Clin Oncol Educ Book 842–851. https://doi.org/10.1200/EDBK_350652

Ciriello G, Miller ML, Aksoy BA et al (2013) Emerging landscape of oncogenic signatures across human cancers. Nat Genet 45:1127–1133. https://doi.org/10.1038/ng.2762

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferreira I, Droop A, Edwards O et al (2021) The clinicopathologic spectrum and genomic landscape of de-/trans-differentiated melanoma. Mod Pathol 34:2009–2019. https://doi.org/10.1038/s41379-021-00857-z

Article  CAS  PubMed  Google Scholar 

Agaimy A, Stoehr R, Hornung A et al (2021) Dedifferentiated and undifferentiated melanomas: report of 35 new cases with literature review and proposal of diagnostic criteria. Am J Surg Pathol 45:240. https://doi.org/10.1097/PAS.0000000000001645

Article  PubMed  Google Scholar 

Chang JC, Alex D, Bott M et al (2019) Comprehensive next-generation sequencing unambiguously distinguishes separate primary lung carcinomas from intrapulmonary metastases: comparison with standard histopathologic approach. Clin Cancer Res 25:7113–7125. https://doi.org/10.1158/1078-0432.CCR-19-1700

Article  CAS  PubMed  PubMed Central  Google Scholar 

Penson A, Camacho N, Zheng Y et al (2020) Development of genome-derived tumor type prediction to inform clinical cancer care. JAMA Oncol 6:84–91. https://doi.org/10.1001/jamaoncol.2019.3985

Article  PubMed  Google Scholar 

Sanjaya P, Maljanen K, Katainen R et al (2023) Mutation-Attention (MuAt): deep representation learning of somatic mutations for tumour typing and subtyping. Genome Med 15:47. https://doi.org/10.1186/s13073-023-01204-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Posner A, Prall OW, Sivakumaran T et al (2023) A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary. J Pathol 259:81–92. https://doi.org/10.1002/path.6022

Article  CAS  PubMed  Google Scholar 

Soh KP, Szczurek E, Sakoparnig T, Beerenwinkel N (2017) Predicting cancer type from tumour DNA signatures. Genome Med 9:104. https://doi.org/10.1186/s13073-017-0493-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nguyen L, Van Hoeck A, Cuppen E (2022) Machine learning-based tissue of origin classification for cancer of unknown primary diagnostics using genome-wide mutation features. Nat Commun 13:4013. https://doi.org/10.1038/s41467-022-31666-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiao W, Atwal G, Polak P et al (2020) A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns. Nat Commun 11:728. https://doi.org/10.1038/s41467-019-13825-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kandoth C, McLellan MD, Vandin F et al (2013) Mutational landscape and significance across 12 major cancer types. Nature 502:333–339. https://doi.org/10.1038/nature12634

Article  CAS  PubMed  PubMed Central  Google Scholar 

Van Hoeck A, Tjoonk NH, van Boxtel R, Cuppen E (2019) Portrait of a cancer: mutational signature analyses for cancer diagnostics. BMC Cancer 19:457. https://doi.org/10.1186/s12885-019-5677-2

Article  PubMed  PubMed Central  Google Scholar 

Hu X, Xu Z, De S (2020) Characteristics of mutational signatures of unknown etiology. NAR Cancer 2:zcaa026. https://doi.org/10.1093/narcan/zcaa026

Article  PubMed  PubMed Central  Google Scholar 

Tothill RW, Li J, Mileshkin L et al (2013) Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary. J Pathol 231:413–423. https://doi.org/10.1002/path.4251

Article  CAS  PubMed  Google Scholar 

Varghese AM, Arora A, Capanu M et al (2017) Clinical and molecular characterization of patients with cancer of unknown primary in the modern era. Ann Oncol 28:3015–3021. https://doi.org/10.1093/annonc/mdx545

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mata DA, Williams EA, Sokol E et al (2022) Prevalence of UV mutational signatures among cutaneous primary tumors. JAMA Netw Open 5:e223833. https://doi.org/10.1001/jamanetworkopen.2022.3833

Article  PubMed  PubMed Central  Google Scholar 

Kasago IS, Chatila WK, Lezcano CM et al (2023) Undifferentiated and dedifferentiated metastatic melanomas masquerading as soft tissue sarcomas: mutational signature analysis and immunotherapy response. Mod Pathol 36:100165. https://doi.org/10.1016/j.modpat.2023.100165

Article  PubMed  Google Scholar 

Bagge RO, Demir A, Karlsson J, et al (2018) Mutational signature and transcriptomic classification analyses as the decisive diagnostic tools for a cancer of unknown primary. JCO Precis Oncol 2:PO.18.00002. https://doi.org/10.1200/PO.18.00002

Wang Z, Zhang T, Wu W et al (2022) Detection and localization of solid tumors utilizing the cancer-type-specific mutational signatures. Front Bioeng Biotechnol 10:883791

Article  PubMed  PubMed Central  Google Scholar 

Zhao Y, Pan Z, Namburi S et al (2020) CUP-AI-Dx: a tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence. eBioMedicine 61:103030. https://doi.org/10.1016/j.ebiom.2020.103030

Article  PubMed  PubMed Central  Google Scholar 

Hong J, Hachem LD, Fehlings MG (2022) A deep learning model to classify neoplastic state and tissue origin from transcriptomic data. Sci Rep 12:9669. https://doi.org/10.1038/s41598-022-13665-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grewal JK, Tessier-Cloutier B, Jones M et al (2019) Application of a neural network whole transcriptome–based pan-cancer method for diagnosis of primary and metastatic cancers. JAMA Netw Open 2:e192597. https://doi.org/10.1001/jamanetworkopen.2019.2597

Article  PubMed  PubMed Central  Google Scholar 

Michuda J, Breschi A, Kapilivsky J et al (2023) Validation of a transcriptome-based assay for classifying cancers of unknown primary origin. Mol Diagn Ther 27:499–511. https://doi.org/10.1007/s40291-023-00650-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abraham J, Heimberger AB, Marshall J et al (2021) Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor type. Transl Oncol 14:101016. https://doi.org/10.1016/j.tranon.2021.101016

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gardiner-Garden M, Frommer M (1987) CpG Islands in vertebrate genomes. J Mol Biol 196:261–282. https://doi.org/10.1016/0022-2836(87)90689-9

Article  CAS  PubMed  Google Scholar 

Sill M, Plass C, Pfister SM, Lipka DB (2020) Molecular tumor classification using DNA methylome analysis. Hum Mol Genet 29:R205–R213. https://doi.org/10.1093/hmg/ddaa147

Article  CAS  PubMed  Google Scholar 

Koelsche C, Schrimpf D, Stichel D et al (2021) Sarcoma classification by DNA methylation profiling. Nat Commun 12:498. https://doi.org/10.1038/s41467-020-20603-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Capper D, Jones DTW, Sill M et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469–474. https://doi.org/10.1038/nature26000

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giacopelli B, Wang M, Cleary A et al (2021) DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia. Genome Res 31:747–761. https://doi.org/10.1101/gr.269233.120